BrycePPortierMD

PubMed

• 22 citations
  Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low ...
  Josef Rüschoff, Michael Friedrich, Iris Nagelmeier, Matthias Kirchner, Lena M Andresen, Karin Salomon, Bryce Portier, Simone T Sredni, Hans Ulrich Schildhaus, Bharat J...> ;Virchows Archiv. 2022 Nov 1
• 3 citations
  Neoplastic Cellularity Assessment in Molecular Testing.
  Kelly A Devereaux, Rhona J Souers, Rondell P Graham, Bryce P Portier, Lea F Surrey, Anna Yemelyanova, Patricia Vasalos, Dimitri G Trembath, Joel T Moncur> ;Archives of Pathology & Laboratory Medicine. 2022 Sep 1
• 1 citations
  Immunohistochemical Validation of Rare Tissues and Antigens With Low Frequency of Occurrence: Recommendations From The Anatomic Pathology Patient Interest Association ...
  Robert L. Lott, Peter V. Riccelli, Elizabeth A. Sheppard, Keith A. Wharton, Eric E. Walk, George Kennedy, Bryce Portier> ;Applied Immunohistochemistry & Molecular Morphology. 2021 May 1
• 22 citations
  Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.
  Jason D. Merker, Kelly A. Devereaux, A. John Iafrate, Suzanne Kamel-Reid, Annette S. Kim, Joel T. Moncur, Stephen B. Montgomery, Rakesh Nagarajan, Bryce P. Portier, Ma...> ;Archives of Pathology & Laboratory Medicine. 2019 Apr 1
• 16 citations
  Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers.
  Michael Barnes, Chukka Srinivas, Isaac Bai, Judith Frederick, Wendy Liu, Anindya Sarkar, Xiuzhong Wang, Yao Nie, Bryce Portier, Monesh Kapadia, Olcay Sertel, Elizabeth...> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2017 Aug 14
• 57 citations
  HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
  Yanjun Hou, Hiroaki Nitta, Lai Wei, Peter M. Banks, Bryce Portier, Anil V. Parwani, Zaibo Li> ;Breast Cancer Research and Treatment. 2017 Aug 10
• 20 citations
  Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells (Leukemia (2014) 28 11 (2155-2164))
  Warren Fiskus, Sunil Sharma, Bhavin Shah, Bryce P. Portier, Santhana G. T. Devaraj, Ka Liu, Swaminathan P. Iyer, David J. Bearss, Kapil N. Bhalla> ;Leukemia. 2017 Jul 1
• 22 citations
  Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ...
  Alana R. Donaldson, Shashirekha Shetty, Zhen Wang, Christine L. Rivera, Bryce P. Portier, G. Thomas Budd, Erinn Downs-Kelly, Christopher Lanigan, Benjamin C. Calhoun> ;Cancer. 2017 Jun 15
• 4 citations
  MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadj...
  Benjamin C. Calhoun, Bryce P. Portier, Zhen Wang, Eugen C. Minca, G. Thomas Budd, Christopher Lanigan, Raymond R. Tubbs, Larry E. Morrison> ;BMC Cancer. 2016 Aug 30
• 15 citations
  Next-generation sequencing of a cohort of pulmonary large cell carcinomas reclassified by world health organization 2015 criteria
  Brandon R. Driver, Bryce P. Portier, Dina R. Mody, Michael T. Deavers, Eric H. Bernicker, Min P. Kim, Bin S. Teh, Jose F. Santacruz, Lisa Kopas, Reginald F. Munden, Ph...> ;Archives of Pathology & Laboratory Medicine. 2016 Apr 1
• 12 citations
  Emerging Biomarkers in Personalized Therapy of Lung Cancer
  Philip T. Cagle, Kirtee Raparia, Bryce P. Portier> ;Advances in Experimental Medicine and Biology. 2016 Oct 1
• 5 citations
  Clinical Validation of a Novel Commercial Reverse Transcription-Quantitative Polymerase Chain Reaction Screening Assay for Detection of ALK Translocations and Amplific...
  Chunyan Liu, Kristi Pepper, Heather Hendrickson, Philip T. Cagle, Bryce Portier> ;Archives of Pathology & Laboratory Medicine. 2016 Jul 1
• 16 citations
  Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas.
  Suzanne M. Crumley, Kristi Pepper, Alexandria T. Phan, Randall J. Olsen, Mary R. Schwartz, Bryce P. Portier> ;Archives of Pathology & Laboratory Medicine. 2016 Jun 1
• 1 citations
  A New Ever-Evolving Paradigm
  Philip T. Cagle, Randall J. Olsen, Bryce P. Portier, Hidehiro Takei, David W. Bernard> ;Archives of Pathology & Laboratory Medicine. 2015 Mar 30
• 117 citations
  BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD
  Warren Fiskus, Sunil Sharma, Jun Qi, Bhavin Shah, Santhana G. T. Devaraj, Christopher Leveque, Bryce P. Portier, Swaminathan P. Iyer, James E. Bradner, Kapil N. Bhalla> ;Molecular Cancer Therapeutics. 2014 Oct 1
• 6 citations
  Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
  Eugen C. Minca, Raymond R. Tubbs, Bryce P. Portier, Zhen Wang, Christopher Lanigan, Mary E. Aronow, Pierre L. Triozzi, Arun D. Singh, James R. Cook, Yogen Saunthararaj...> ;Cancer Genetics. 2014 Jul 1
• 152 citations
  Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
  Warren Fiskus, Sunil Sharma, Jun Qi, John A Valenta, Leasha J. Schaub, Bhavin Shah, Karissa Peth, Bryce P. Portier, Melissa Rodriguez, Santhana G. T. Devaraj, Ming Zha...> ;Molecular Cancer Therapeutics. 2014 May 1
• 21 citations
  Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing.
  Bryce P. Portier, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Rajesh R. Singh, Mark J. Routbort, Brian Handal, Neelima Reddy, Bedia A. Barkoh, Zhuang Zuo, L. Jeffrey...> ;American Journal of Clinical Pathology. 2014 Apr 1
• Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
  Fiskus, W.,Sharma, S.,Shah, B.,Portier, B. P.,Devaraj, S. G.,Liu, K.,Iyer, S. P.,Bearss, D.,Bhalla, K. N.> ;Leukemia. 2014 Apr 05
• 162 citations
  Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagn...
  Rashmi Kanagal-Shamanna, Bryce P. Portier, Rajesh R. Singh, Mark J. Routbort, Kenneth D. Aldape, Brian Handal, Hamed Rahimi, Neelima Reddy, Bedia A. Barkoh, Bal Mukund...> ;Modern Pathology. 2014 Feb 1
• 24 citations
  Ultrasensitive RNA In Situ Hybridization for Detection of Restricted Clonal Expression of Low-Abundance Immunoglobulin Light Chain mRNA in B-Cell Lymphoproliferative D...
  Raymond R. Tubbs, Hongwei Wang, Zhen Wang, Eugen C. Minca, Bryce P. Portier, Aaron M. Gruver, Christopher Lanigan, Yuling Luo, James R. Cook, Xiao Jun Ma> ;American Journal of Clinical Pathology. 2013 Nov 1
• 63 citations
  Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
  Parag Parekh, Sanchit Kamble, Nianxi Zhao, Zihua Zeng, Bryce P. Portier, Youli Zu> ;Biomaterials. 2013 Nov 1
• 23 citations
  HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma
  Bryce P. Portier, Eugen C. Minca, Zhen Wang, Christopher Lanigan, Aaron M. Gruver, Erinn Downs-Kelly, G. Thomas Budd, Raymond R. Tubbs> ;Oncotarget. 2013 Aug 30
• 103 citations
  ALK Status Testing in Non–Small Cell Lung Carcinoma: Correlation Between Ultrasensitive IHC and FISH
  Eugen C. Minca, Bryce P. Portier, Zhen Wang, Christopher Lanigan, Carol Farver, Yan Feng, Patrick C. Ma, Valeria Arrossi, Nathan A. Pennell, Raymond R. Tubbs> ;The Journal of Molecular Diagnostics. 2013 May 1
• 50 citations
  Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
  Zhen Wang, Bryce P. Portier, Aaron M. Gruver, Son Bui, Hongwei Wang, Nan Su, Hong Thuy Vo, Xiao Jun Ma, Yuling Luo, G. Thomas Budd, Raymond R. Tubbs> ;The Journal of Molecular Diagnostics. 2013 Mar 1
• Join now to see all